Market closedNon-fractional
OPKO Health/OPK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About OPKO Health
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
Ticker
OPK
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Providers and Services
Headquarters
Miami, United States
Employees
3,930
Website
www.opko.com
OPKO Health Metrics
BasicAdvanced
$990M
Market cap
-
P/E ratio
-$0.34
EPS
1.65
Beta
-
Dividend rate
Price and volume
Market cap
$990M
Beta
1.65
Financial strength
Current ratio
1.915
Quick ratio
0.954
Long term debt to equity
31.545
Total debt to equity
34.315
Interest coverage (TTM)
-11.18%
Management effectiveness
Return on assets (TTM)
-6.01%
Return on equity (TTM)
-18.00%
Valuation
Price to revenue (TTM)
1.315
Price to book
0.79
Price to tangible book (TTM)
-6.48
Price to free cash flow (TTM)
-17.887
Growth
Revenue change (TTM)
-12.38%
Earnings per share change (TTM)
-13.95%
3-year revenue growth (CAGR)
-23.26%
3-year earnings per share growth (CAGR)
21.82%
What the Analysts think about OPKO Health
Analyst Ratings
Majority rating from 6 analysts.
OPKO Health Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$174M
-4.56%
Net income
-$82M
23.19%
Profit margin
-47.11%
29.07%
OPKO Health Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.03
-$0.11
-$0.09
-$0.12
-
Expected
-$0.07
-$0.10
-$0.09
-$0.10
-$0.10
Surprise
-63.62%
10.00%
2.27%
26.32%
-
OPKO Health News
AllArticlesVideos
OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments
GlobeNewsWire·1 week ago
OPKO Health to Participate in the Jefferies Global Healthcare Conference
GlobeNewsWire·2 months ago
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for OPKO Health stock?
OPKO Health (OPK) has a market cap of $990M as of July 26, 2024.
What is the P/E ratio for OPKO Health stock?
The price to earnings (P/E) ratio for OPKO Health (OPK) stock is 0 as of July 26, 2024.
Does OPKO Health stock pay dividends?
No, OPKO Health (OPK) stock does not pay dividends to its shareholders as of July 26, 2024.
When is the next OPKO Health dividend payment date?
OPKO Health (OPK) stock does not pay dividends to its shareholders.
What is the beta indicator for OPKO Health?
OPKO Health (OPK) has a beta rating of 1.65. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell OPKO Health stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.